Skip to content
Clinical Trials – home

Chlorpromazine Hydrochloride: A Comprehensive Guide for Patients

3 / 3
trials open to patients / all trials
5+
Countries

In short

Chlorpromazine Hydrochloride, a versatile antipsychotic medication, has been the subject of various clinical trials exploring its potential uses beyond its primary psychiatric applications. These studies investigate its efficacy in treating conditions ranging from agitated delirium to COVID-19, as well as its use in medical imaging procedures and cancer treatment. This article summarizes key findings from recent clinical trials involving Chlorpromazine Hydrochloride, highlighting its diverse potential applications in modern medicine.

What is Chlorpromazine Hydrochloride?

Chlorpromazine hydrochloride is a medication that has been used for over half a century in the treatment of various medical conditions. It belongs to a class of drugs called antipsychotics. Chlorpromazine is also known by several other names, including Largactil, Thorazine, and Neurazine.

Medical Uses of Chlorpromazine

Chlorpromazine is primarily used to treat mental health conditions, but it has several other medical applications as well. Some of the conditions it is used to treat include:

  • Psychotic disorders: Chlorpromazine helps manage symptoms of conditions like schizophrenia.
  • Nausea and vomiting: It can help control severe nausea and vomiting in some patients.
  • Pre-surgery anxiety: Chlorpromazine may be used to relieve restlessness and apprehension before surgery.
  • Acute intermittent porphyria: This is a rare inherited blood disorder that chlorpromazine can help manage.
  • Tetanus: Chlorpromazine can be used as an additional treatment for tetanus, a serious bacterial infection.
  • Manic episodes: It can help control symptoms of manic-depressive illness (also known as bipolar disorder).
  • Intractable hiccups: In some cases, chlorpromazine is used to relieve persistent hiccups that don't respond to other treatments.

How Chlorpromazine Works

Chlorpromazine works by affecting various chemical systems in the brain. Its main action is blocking a specific type of receptor called the dopamine D2 receptor. This helps to reduce excessive dopamine activity in the brain, which is thought to be responsible for some symptoms of psychotic disorders.

In addition to its effects on dopamine, chlorpromazine also influences other brain chemicals and systems. This wide-ranging action contributes to its various uses in medicine.

How Chlorpromazine is Administered

Chlorpromazine can be given in several ways, depending on the condition being treated and the patient's needs:

  • Oral tablets: The most common form is tablets taken by mouth. The dosage can vary widely, from as low as 12.5 mg to as high as 300 mg per day, depending on the condition and the patient's response.
  • Intravenous (IV) injection: In some cases, particularly in hospital settings, chlorpromazine may be given by injection into a vein.
  • Retrobulbar injection: In very specific cases, such as for treating severe eye pain in blind eyes, chlorpromazine may be injected behind the eye.

Potential Side Effects

Like all medications, chlorpromazine can cause side effects. Some potential side effects include:

  • Drowsiness or sedation
  • Changes in heart rate or blood pressure
  • Movement disorders (extrapyramidal symptoms)
  • Changes in blood cell counts
  • Liver function changes
  • Alterations in heart rhythm (seen on ECG)

It's important to note that not everyone experiences these side effects, and your doctor will monitor you closely while you're taking this medication.

Current Research and New Potential Uses

Researchers are currently exploring new potential uses for chlorpromazine. Some areas of ongoing research include:

  • COVID-19 treatment: Some studies are investigating whether chlorpromazine could help treat COVID-19 by interfering with the virus's ability to enter cells.
  • Cancer treatment: Researchers are studying whether chlorpromazine could be useful in treating certain types of cancer, including glioblastoma (a type of brain cancer) and colon cancer. It appears to have effects that could slow cancer cell growth.
  • Delirium management: Studies are looking at how chlorpromazine compares to other medications in managing agitated delirium, a state of severe confusion that can occur in hospitalized patients.

It's important to remember that these are areas of ongoing research, and chlorpromazine is not currently approved for these uses. Always follow your doctor's advice about medications and never use a medication for a purpose other than what it was prescribed for.

Questions people often ask

Conditions where Chlorpromazine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Chlorpromazine Hydrochloride

Recruiting trials first

See all 3 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).